People channel feed – Endpoints News

People channel feed

Longtime Sanofi R&D chief Elias Zerhouni is on his way out, handing the research reins to Roche vet John Reed

8 years ago

The under-40s: How does the next generation of biopharma executives view the future?

8 years ago

After fruitless talks, a bid from Vas and plenty of patience, AveXis CEO Sean Nolan slowly reeled in an $8.7B deal

8 years ago

Arcturus takes another legal stab at former CEO as public battle turns serious for the company

8 years ago

Badrul Chowdhury jumps ship at the FDA and moves to AstraZeneca, joining an exodus of agency officials

8 years ago

Novartis poaches Bristol-Myers/Amgen vet John Tsai for top drug development post in a $9B organization

8 years ago

GlaxoSmithKline’s Hal Barron poaches Genentech’s top cancer drug dealmaker for his new R&D team

8 years ago

Retire? Bill Chin’s tried it three times, and he’d rather be working at Frequency Therapeutics

8 years ago

FDA launches criminal probe into unauthorized herpes vaccine R&D backed by Peter Thiel

8 years ago

Vivek Ramaswamy is diving into RNA, launching a new biotech with Arbutus and a team of vets

8 years ago

Buckle up: Biotech board activist Alex Denner is out to shake things up at Ironwood

8 years ago

Top AstraZeneca I/O vet Robert Iannone jumps to Immunomedics as R&D chief as BLA looms

8 years ago

Jackie Fouse recruits an executive team and beefs up the dermatology pipeline at Dermavant

8 years ago

In sudden revamp, Celgene CEO Alles bids his COO goodbye and looks to regain confidence with management shuffle

8 years ago

Backed by giants, antibiotics upstart Macrolide gets $20M and an ex-Novartis exec as CEO

8 years ago

In a bitter brawl, Arcturus details ex-CEO's alleged misconducts in lawsuit and open letter

8 years ago

Revenue down? No worries for Gilead CEO Milligan as compensation swells to $15.4M

8 years ago

Novo Nordisk's pick for new chairman signals its ongoing pursuit of M&A deals

8 years ago

Shakeup at China FDA after chief vaults to the helm of a regulatory umbrella group, new agency head named

8 years ago

Despite some nagging demerits, Incyte CEO Hervé Hoppenot still bagged $16M in compensation — a 35% increase

8 years ago

Falling behind giant migraine drug rivals, Alder ousts founder Randy Schatzman — could a buyout be next?

8 years ago

Pfizer persuades CEO Ian Read to stay on for 1 more year, adding $8M bonus and bumping pay package to $28M

8 years ago

Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package

8 years ago

From drugmaker to drug manager: Ex-GSK chief Andrew Witty jumps to the helm of giant Optum

8 years ago

First page Previous page 88 89 909192 93 94 Next page Last page